Blog

Hagop Youssoufian: I’m very pleased to serve on the Clinical and Regulatory Advisory Board of AffyImmune Therapeutics

A collage photo of Hagop Youssoufian and AffyImmune Therapeutics.

Apr 14, 2024, 06:47

Hagop Youssoufian: I’m very pleased to serve on the Clinical and Regulatory Advisory Board of AffyImmune Therapeutics

Hagop Youssoufian, Youssoufian Consulting, LLC, posted on LinkedIn:

“I’m very pleased to serve on the Clinical and Regulatory Advisory Board of AffyImmune Therapeutics, which is aspiring to develop revolutionary CAR T therapies for a highly lethal form of thyroid cancer as well as lung cancer.”

View the article attached to the post.
Source: Hagop Youssoufian/LinkedIn

AffyImmune Therapeutics cancer CAR T therapies Clinical and Regulatory Advisory Board of AffyImmune Therapeutics Hagop Youssoufian highly lethal form cancer Lung cancer OncoDaily Oncology Revolutionary Therapies thyroid cancer

New Paper Alert! HR+ Breast Cancer: Efficacy of Subsequent Treatments After CDK4/6 Inhibitor Progression

Carlos Rodriguez-Galindo: The Man Who Will Cure the World

Esophageal Cancer: Symptoms, Causes, Stages, Diagnosis & Treatment

Faster, Flexible and Affordable: Mikhail Groubman on Building a Global Legacy in Clinical Research in an Untapped Market

Invest in Health Policy: A Conversation with Professor Andreas Charalambous

Special Coverage